Galaxy CCRO is a Texas-based clinical research and biotechnology company advancing next-generation point-of-care diagnostics for time-critical medical conditions.

Founded by clinicians and scientists committed to closing critical diagnostic gaps, Galaxy is developing rapid blood-based biomarker technologies designed to improve triage, accelerate treatment decisions, and enhance patient outcomes in acute care settings.

Our flagship program focuses on stroke — one of the leading causes of death and long-term disability worldwide — where rapid biochemical insight may transform emergency response and therapeutic timing.

Galaxy integrates biomarker science, lateral flow assay technology, and quantitative detection platforms to bring laboratory-grade insights to the bedside.

Beyond human diagnostics, Galaxy is also expanding protein-detection platforms to address urgent public health challenges, including Chronic Wasting Disease (CWD). We recognize that food security is national security, and we are advancing innovative research designed to protect wildlife ecosystems, safeguard agricultural resources, and ultimately save lives.

We collaborate with leading scientists, clinicians, and global partners to translate breakthrough science into practical, deployable solutions.

Galaxy CCRO — Redefining rapid diagnostics when every minute matters.

- Point-of-Care Stroke Diagnostics
- Biomarker Kinetics
- GSTP1 Quantitative Assays
- Acute Stroke Triage Innovation
- Lateral Flow Diagnostic Platforms
- Near-Patient Testing Solutions
- Clinical Performance Validation
- Protein-Based Rapid Diagnostics
- Neurovascular Biomarker Research
- Diagnostic Commercialization
- Chronic Wasting Disease Detection
- Food Security & Biosecurity Innovation

GALAXY CCRO, INC.

Org chart

Teams

Offices

GALAXY CCRO, INC.

Org chart

Teams

Offices

Related companies